Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcello Tiseo

Showing results (21-30 of 362) with videos related to

Pageof 37
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 20, 2023
Chasing EGFR Mutations in the Plasma of Patients With Resected NSCLC: Lessons in the ADAURA EraFrancesco Facchinetti, Pasi A Jänne, Marcello Tiseo
The New England Journal of Medicine|February 27, 2020
Nivolumab plus Ipilimumab in Non-Small-Cell Lung CancerMelissa Bersanelli, Marcello Tiseo, Giuseppe L Banna
The New England Journal of Medicine|May 5, 2016
Crizotinib Resensitization by Compound MutationPaola Bordi, Marzia Del Re, Marcello Tiseo
Translational Lung Cancer Research|May 19, 2020
Cystic brain metastases and <i>RET</i> fusion in lung cancerJordi Remon, Francesco Facchinetti, Benjamin Besse, et al.
BMC Cancer|August 14, 2016
Metabolic complete response with vinflunine as second-line therapy in a kidney-transplanted patient with advanced urothelial carcinoma: a case reportPaola Bordi, Marcello Tiseo, Giorgio Baldari, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 15, 2013
"Pseudocavitation" in thymic carcinoma during treatment with sunitinibMarcello Tiseo, Arun Rajan, Anish Thomas, et al.
Expert Review of Anticancer Therapy|April 21, 2009
First-line treatment in advanced non-small-cell lung cancer: the emerging role of the histologic subtypeMarcello Tiseo, Marco Bartolotti, Francesco Gelsomino, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 7, 2024
Benefit With No Target: Long-Term Outcomes of Chemoimmunotherapy in "PD-L1 Negative" NSCLCFabiana Perrone, Alessandro Leonetti, Marcello Tiseo, et al.
Translational Lung Cancer Research|December 3, 2015
Circulating DNA in diagnosis and monitoring EGFR gene mutations in advanced non-small cell lung cancerPaola Bordi, Marzia Del Re, Romano Danesi, et al.
Translational Lung Cancer Research|July 23, 2021
First-line immunotherapy in non-small cell lung cancer patients with poor performance status: a systematic review and meta-analysisFrancesco Facchinetti, Massimo Di Maio, Fabiana Perrone, et al.
Pageof 37

Showing results (21-30 of 362) with videos related to

Sort By:
Pageof 37
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 20, 2023
Chasing EGFR Mutations in the Plasma of Patients With Resected NSCLC: Lessons in the ADAURA EraFrancesco Facchinetti, Pasi A Jänne, Marcello Tiseo
The New England Journal of Medicine|February 27, 2020
Nivolumab plus Ipilimumab in Non-Small-Cell Lung CancerMelissa Bersanelli, Marcello Tiseo, Giuseppe L Banna
The New England Journal of Medicine|May 5, 2016
Crizotinib Resensitization by Compound MutationPaola Bordi, Marzia Del Re, Marcello Tiseo
Translational Lung Cancer Research|May 19, 2020
Cystic brain metastases and <i>RET</i> fusion in lung cancerJordi Remon, Francesco Facchinetti, Benjamin Besse, et al.
BMC Cancer|August 14, 2016
Metabolic complete response with vinflunine as second-line therapy in a kidney-transplanted patient with advanced urothelial carcinoma: a case reportPaola Bordi, Marcello Tiseo, Giorgio Baldari, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 15, 2013
"Pseudocavitation" in thymic carcinoma during treatment with sunitinibMarcello Tiseo, Arun Rajan, Anish Thomas, et al.
Expert Review of Anticancer Therapy|April 21, 2009
First-line treatment in advanced non-small-cell lung cancer: the emerging role of the histologic subtypeMarcello Tiseo, Marco Bartolotti, Francesco Gelsomino, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 7, 2024
Benefit With No Target: Long-Term Outcomes of Chemoimmunotherapy in "PD-L1 Negative" NSCLCFabiana Perrone, Alessandro Leonetti, Marcello Tiseo, et al.
Translational Lung Cancer Research|December 3, 2015
Circulating DNA in diagnosis and monitoring EGFR gene mutations in advanced non-small cell lung cancerPaola Bordi, Marzia Del Re, Romano Danesi, et al.
Translational Lung Cancer Research|July 23, 2021
First-line immunotherapy in non-small cell lung cancer patients with poor performance status: a systematic review and meta-analysisFrancesco Facchinetti, Massimo Di Maio, Fabiana Perrone, et al.
Pageof 37